Entry |
|
Name |
Flurbiprofen sodium (USP); Ocufen (TN) |
Product |
|
Generic |
|
Formula |
C15H12FO2. 2H2O. Na
|
Exact mass |
302.093
|
Mol weight |
302.2733
|
Structure |
|
Simcomp |
|
Class |
Anti-inflammatory
DG01504 Nonsteroidal anti-inflammatory drug (NSAID)
DG01908 Anti-inflammatory drug, propionic acid derivatives
Metabolizing enzyme substrate
DG01642 CYP2C9 substrate
|
Remark |
Product (DG00755): | D00330<JP/US> D01475<JP> D02290<US> |
|
Efficacy |
Analgesic, Anti-inflammatory, COX inhibitor |
Comment |
Propionic acid derivative
Inhibition of intraoperative miosis
|
Target |
|
Pathway |
|
Metabolism |
Enzyme: CYP2C9 [HSA: 1559]
|
Interaction |
|
Structure map |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
M MUSCULO-SKELETAL SYSTEM
M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
M01AE Propionic acid derivatives
M01AE09 Flurbiprofen
D02290 Flurbiprofen sodium (USP) <US>
M02 TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
M02A TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
M02AA Antiinflammatory preparations, non-steroids for topical use
M02AA19 Flurbiprofen
D02290 Flurbiprofen sodium (USP) <US>
R RESPIRATORY SYSTEM
R02 THROAT PREPARATIONS
R02A THROAT PREPARATIONS
R02AX Other throat preparations
R02AX01 Flurbiprofen
D02290 Flurbiprofen sodium (USP) <US>
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01B ANTIINFLAMMATORY AGENTS
S01BC Antiinflammatory agents, non-steroids
S01BC04 Flurbiprofen
D02290 Flurbiprofen sodium (USP) <US>
USP drug classification [BR:br08302]
Analgesics
Nonsteroidal Anti-inflammatory Drugs
Flurbiprofen
D02290 Flurbiprofen sodium (USP)
Ophthalmic Agents
Ophthalmic Anti-inflammatories
Nonsteroidal Anti-Inflammatory Drugs, Ophthalmic
Flurbiprofen
D02290 Flurbiprofen sodium (USP)
Drug groups [BR:br08330]
Anti-inflammatory
DG01504 Nonsteroidal anti-inflammatory drug (NSAID)
DG01908 Anti-inflammatory drug, propionic acid derivatives
DG00755 Flurbiprofen
D02290 Flurbiprofen sodium
Metabolizing enzyme substrate
DG01642 CYP2C9 substrate
DG00755 Flurbiprofen
D02290 Flurbiprofen sodium
Drug classes [BR:br08332]
Anti-inflammatory
DG01504 Nonsteroidal anti-inflammatory drug (NSAID)
D02290 Flurbiprofen sodium
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
Prostaglandin synthase
PTGS1 (COX1)
D02290 Flurbiprofen sodium (USP) <US>
PTGS2 (COX2)
D02290 Flurbiprofen sodium (USP) <US>
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D02290
Pharmacogenomic biomarkers [br08341.html]
Polymorphisms and mutations affecting drug response
D02290
Drug groups [BR:br08330]
Anti-inflammatory
DG01504 Nonsteroidal anti-inflammatory drug (NSAID)
DG01908 Anti-inflammatory drug, propionic acid derivatives
DG00755 Flurbiprofen
Metabolizing enzyme substrate
DG01642 CYP2C9 substrate
DG00755 Flurbiprofen
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 21
1 O0 O 38.2961 -15.7791
2 C8x C 28.2100 -16.5900
3 C8y C 28.2100 -15.1900
4 C8x C 26.9500 -14.4900
5 C8x C 25.7600 -15.1900
6 C8x C 25.7600 -16.5900
7 C8x C 26.9500 -17.2900
8 C8y C 29.4000 -14.4900
9 C8y C 30.5900 -15.1900
10 C8x C 31.8500 -14.4900
11 C8y C 31.8500 -13.0900
12 C8x C 30.5900 -12.3900
13 C8x C 29.4000 -13.0900
14 X F 30.5900 -16.5900
15 C1c C 33.0400 -12.3900
16 C6a C 34.2300 -13.0900
17 C1a C 33.0400 -11.0600
18 O6a O 34.2300 -14.4900
19 O6a O 35.4900 -12.3900 #-
20 Z Na 37.2400 -12.4600 #+
21 O0 O 38.2961 -15.7791
BOND 19
1 5 6 2
2 6 7 1
3 8 9 2
4 9 10 1
5 10 11 2
6 11 12 1
7 12 13 2
8 13 8 1
9 7 2 2
10 9 14 1
11 11 15 1
12 3 8 1
13 15 16 1
14 2 3 1
15 15 17 1
16 3 4 2
17 16 18 2
18 4 5 1
19 16 19 1
BRACKET 1 36.4000 -16.7300 36.4000 -14.7000
1 38.8500 -14.7000 38.8500 -16.7300
1 2
ORIGINAL 1 1
REPEAT 1 21
|